Emma McCarthy

Anticholinergics Should Not Be Used to Treat Tardive Dyskinesia: Insights from an Expert Panel of Psychiatry and Neurology Healthcare Professionals

Abstract: Background: Treating tardive dyskinesia (TD) with anticholinergics is a common practice, despite the lack of supportive evidence and potential to worsen TD. Methods: Eight move...

Emma McCarthy ;

Dawn Vanderhoef ;

01/19/2023

Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia

Abstract: Background: Valbenazine is a once-daily VMAT2 inhibitor approved for the treatment of tardive dyskinesia (TD). Data from a 48-week, open-label study of valbenazine (KINECT 4 [NC...

Emma McCarthy ;

Khodayar Farahmand , PharmD;

01/19/2023

Treatment Success and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies

Abstract: Background: In clinical trials of valbenazine, which is approved for once-daily treatment of tardive dyskinesia (TD), psychiatric stability was assessed along with global change...

Andrew J. Cutler , MD;

Emma McCarthy ;

01/19/2023